Renaissance Technologies’s Zevra Therapeutics ZVRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-112,800	Closed	-$553K	–	3952
2024 Q2	$553K	Sell	112,800 -42,600	-27%	-$202K	﹤0.01%	2655
2024 Q1	$901K	Sell	155,400 -15,100	-9%	-$92.8K	﹤0.01%	2546
2023 Q4	$1.12M	Buy	170,500 +37,800	+28%	+$177K	﹤0.01%	2336
2023 Q3	$640K	Buy	132,700 +800	+0.6%	+$3.99K	﹤0.01%	2599
2023 Q2	$673K	Buy	131,900 +28,100	+27%	+$151K	﹤0.01%	2712
2023 Q1	$571K	Buy	103,800 +22,800	+28%	+$121K	﹤0.01%	2813
2022 Q4	$372K	Buy	81,000 +9,100	+13%	+$46.2K	﹤0.01%	3121
2022 Q3	$449K	Sell	71,900 -31,494	-30%	-$178K	﹤0.01%	2987
2022 Q2	$461K	Sell	103,394 -77,397	-43%	-$353K	﹤0.01%	3208
2022 Q1	$909K	Buy	180,791 +162,291	+877%	+$1.03M	﹤0.01%	2793
2021 Q4	$161K	Sell	18,500 -147,100	-89%	-$1.31M	﹤0.01%	3587
2021 Q3	$1.54M	Buy	+165,600	New	+$1.67M	﹤0.01%	2288
2020 Q2	–	Sell	-10,662	Closed	-$38K	–	3818
2020 Q1	$38K	Buy	+10,662	New	+$59K	﹤0.01%	3344
2018 Q4	–	Sell	-6,488	Closed	-$498K	–	3663
2018 Q3	$498K	Sell	6,488 -4,875	-43%	-$381K	﹤0.01%	2849
2018 Q2	$1.18M	Buy	11,363 +5,713	+101%	+$558K	﹤0.01%	2530
2018 Q1	$714K	Buy	+5,650	New	+$546K	﹤0.01%	2793